Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q3 FY25 results · Oct–Dec 2024
Acutaas Chemicals reported revenue from operations of ₹274.99 crore (up 65.2% from Q3 FY24) and net profit of ₹45.45 crore (up 155.1% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 274.99 | 166.44 | +65.2% | 246.73 | +11.5% |
| Other income | 1.67 | 3.49 | −52.2% | 8.44 | −80.2% |
| Total income | 276.66 | 169.94 | +62.8% | 255.17 | +8.4% |
| Profit before tax | 63.33 | 23.70 | +167.2% | 50.04 | +26.6% |
| Net profit for the period | 45.45 | 17.81 | +155.1% | 37.57 | +21.0% |
| Attributable to shareholders of the company | 44.95 | 16.75 | +168.3% | 37.33 | +20.4% |
| EPS, basic (₹) | 11.35 | 4.83 | not comparable | 9.38 | +21.0% |
| Net margin (%) | 16.5 | 10.7 | 15.2 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 270.94 | 161.70 | +67.6% | 243.59 | +11.2% |
| Other income | 2.17 | 2.87 | −24.5% | 8.58 | −74.7% |
| Total income | 273.11 | 164.57 | +66.0% | 252.17 | +8.3% |
| Profit before tax | 62.54 | 20.34 | +207.5% | 50.02 | +25.0% |
| Net profit for the period | 45.31 | 15.70 | +188.5% | 37.68 | +20.2% |
| EPS, basic (₹) | 11.31 | 4.26 | not comparable | 9.41 | +20.2% |
| Net margin (%) | 16.7 | 9.7 | 15.5 |
Consolidated
- Filed with BSE
- 29 Jan 2025, 15:57 IST
- Board meeting
- 28 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 Jan 2025, 15:57 IST
- Board meeting
- 28 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE